Extracellular vesicles versus synthetic nanoparticles for drug delivery
<!-- START_ABSTRACT -->
<p>
Cell-released biological nanoparticles, that is, extracellular vesicles (EVs), are emerging drug carriers with high complexity. EV-based drug delivery exploits intrinsic mechanisms for molecular transport in the body. Integrating EV biology and manufacturing with clinical insights from synthetic nanoparticles is likely to substantially advance the field of drug delivery.
</p>
<!-- END_ABSTRACT -->
<!-- START_TEMPLATE -->
<ul>
<li>
Source:
</li>
<li>
Tags:
</li>
</ul>
<!-- END_TEMPLATE -->
Backlinks
These are the other notes that link to this one.
Nothing links here, how did you reach this page then?
Comment
Share your thoughts on this note. Comments are not public, they are
messages sent directly to my inbox.
Aquiles Carattino
This note you are reading is part
of my digital garden. Follow the
links to learn more, and remember that these notes evolve over time. After all,
this website is not a
blog.